These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37921183)

  • 1. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β.
    Sai Varshini M; Reddy RA; Krishnamurthy PT; Selvaraj D
    Curr Comput Aided Drug Des; 2024; 20(6):998-1012. PubMed ID: 37921183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
    Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
    J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3β as targets for Alzheimer's disease.
    Kumar A; Srivastava G; Sharma A
    Comput Biol Chem; 2017 Dec; 71():1-9. PubMed ID: 28950235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Potential Lead Compound from
    Youn K; Jun M
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new BACE1 inhibitors for treating Alzheimer's disease.
    Kushwaha P; Singh V; Somvanshi P; Bhardwaj T; Barreto GE; Ashraf GM; Mishra BN; Chundawat RS; Haque S
    J Mol Model; 2021 Jan; 27(2):58. PubMed ID: 33517514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into the inhibitory mechanism of bi-functional bis-tryptoline triazole against β-secretase (BACE1) enzyme.
    Narang SS; Goyal D; Goyal B
    Amino Acids; 2019 Nov; 51(10-12):1593-1607. PubMed ID: 31654211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review.
    Rampa A; Gobbi S; Concetta Di Martino RM; Belluti F; Bisi A
    Curr Top Med Chem; 2017; 17(31):3361-3369. PubMed ID: 29332582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment.
    Ugbaja SC; Sanusi ZK; Appiah-Kubi P; Lawal MM; Kumalo HM
    Biophys Chem; 2021 Mar; 270():106536. PubMed ID: 33387910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico screening of potential β-secretase (BACE1) inhibitors from VIETHERB database.
    Nhung NT; Duong N; Phung HTT; Vo QV; Tam NM
    J Mol Model; 2022 Feb; 28(3):60. PubMed ID: 35156141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying potential Alzheimer's disease therapeutics through GSK-3β inhibition: A molecular docking and dynamics approach.
    Mohammadi Y; Emadi R; Maddahi A; Shirdel S; Morowvat MH
    Comput Biol Chem; 2024 Aug; 111():108095. PubMed ID: 38805865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Pueraria tuberosa (Willd.) DC. to rescue cognitive decline associated with BACE1 protein of Alzheimer's disease on Drosophila model: An integrated molecular modeling and in vivo approach.
    Ahuja A; Tyagi PK; Tyagi S; Kumar A; Kumar M; Sharifi-Rad J
    Int J Biol Macromol; 2021 May; 179():586-600. PubMed ID: 33705837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A; Roy S; Tripathi S; Sharma A
    J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments.
    Bottegoni G; Veronesi M; Bisignano P; Kacker P; Favia AD; Cavalli A
    ChemMedChem; 2016 Jun; 11(12):1259-63. PubMed ID: 26663255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach.
    Karpagam V; Sathishkumar N; Sathiyamoorthy S; Rasappan P; Shila S; Kim YJ; Yang DC
    Comput Biol Med; 2013 Sep; 43(8):1037-44. PubMed ID: 23816176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.
    Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U
    J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational identification of promising therapeutics via BACE1 Targeting: Implications for Alzheimer's disease.
    Murad HAS; Moawadh MS; Alzahrani A; Alkathiri AS; Almutairi A; Alhassoun MI; Alniwaider RA; Habib AH; Sain ZM; Misbahuddin M Rafeeq
    Cell Mol Biol (Noisy-le-grand); 2024 Sep; 70(8):64-75. PubMed ID: 39262261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.